Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation

Keyphrases

• Ischemic Complication 100%
• Bleeding Complications 100%
• Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) 100%
• Optimal Test 100%
• Bleeding Risk 66%
• Activated Partial Thromboplastin Time (aPTT) 66%
• Platelet Aggregation 66%
• Thrombosis 66%
• Bleeding 66%
• Heparin 66%
• Clinical Outcomes 33%
• Thromboelastography 33%
• Risk Stratification 33%
• Clinical High Risk 33%
• Thrombosis Risk 33%
• Thrombin Generation 33%
• Fibrinogen 33%
• Activated Clotting Time 33%
• Arterial Thrombosis 33%
• Complementary Tests 33%
• Anti-Xa Level 33%
• Venous Thrombosis 33%
• Hemostasis 33%
• Systemic Anticoagulation 33%
• Prothrombin Time 33%
• Ultra-high Frequency 33%
• Platelet Function Analyzer 33%
• Systemic Embolism 33%
• Negative Predictive Value 33%
• Von Willebrand Disease 33%
• Coagulation 33%
• Platelet Count 33%
• Von Willebrand Factor 33%
• Platelet Function 33%
• Clot 33%
• Antithrombin 33%

Medicine and Dentistry

• Bleeding 100%
• Extracorporeal Membrane Oxygenation 100%
• Thrombosis 60%
• Thrombocyte Function 40%
• Thrombocyte Aggregation 40%
• Partial Thromboplastin Time 40%
• Heparin 40%
• Risk Stratification 20%
• Artery Thrombosis 20%
• Von Willebrand Factor 20%
• Phlebothrombosis 20%
• Apoplexy 20%
• Anticoagulation 20%
• Platelet 20%
• Thromboelastography 20%
• Antithrombin 20%
• Activated Clotting Time 20%
• Blood Stasis 20%
• Fibrinogen 20%
• Prothrombin Time 20%
• Thrombin 20%